Criteria Bio Ventures participates in NRG Therapeutics’ £50m Series B round

by CriteriaCaixa

The financing was led by SV Health Investors’ Dementia Discovery Fund, joined by a syndicate of leading international life science venture investors: British Business Bank, M Ventures, Novartis Vent...

Read more

SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines

by Asabys Partners

The Series B financing was co-led by new investors EQT Life Sciences and Sanofi Ventures, with participation from Roche Venture Fund, as well as all existing investors: New Enterprise Associates, UCB ...

Read more

Tagworks Pharmaceuticals Announces $65 Million in Series A Financing led by Ysios Capital and Gilde Healthcare, to Advance Click-to-Release Therapeutics

by Ysios Capital

Tagworks Pharmaceuticals, the pioneer of Click-to-Release chemistry designed to deliver more effective and safer systemic therapies, today announced a $65 million Series A financing led by Ysios Capit...

Read more

SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline

by Ysios Capital

SpliceBio, a biotechnology company exploiting protein splicing to develop next generation gene therapies, today announced the completion of an oversubscribed €50 million series A financing. The fina...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Xcalibur Smart Mapping strengthens its g...

by MCH Private Equity

​Xcalibur Smart Mapping, recognised as the global leader in airborne...

Photos Stream